Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CHKA | P35790 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | GABRP | O00591 | 1/20 | 0.38 |
| ▸ | GABRD | O14764 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azepane SCHEMBL29776406 | 1.00 | ALDH1A1 (0.56) | ALDH1A1ACHEKDM4EKMT2AMAPT | |
| Piperidine SCHEMBL10778074 | 1.00 | ALDH1A1 (0.56) | ALDH1A1ACHEKDM4EKMT2AMAPT | |
| Azepane SCHEMBL9998550 | 1.00 | ALDH1A1 (0.56) | ALDH1A1ACHEKDM4EKMT2AMAPT | |
| Piperidine SCHEMBL8761997 | 1.00 | ALDH1A1 (0.56) | ALDH1A1ACHEKDM4EKMT2AMAPT | |
| Piperidine SCHEMBL3873742 | 0.97 | ALDH1A1 (0.53) | ALDH1A1ACHEKDM4EKMT2AMAPT | |
| Azepane SCHEMBL20740114 | 0.97 | ALDH1A1 (0.53) | ALDH1A1ACHEKDM4EKMT2AMAPT | |
| Pyrrolidine SCHEMBL1793163 | 0.97 | — | — | |
| Pyrrolidine SCHEMBL15387295 | 0.97 | ALDH1A1 (0.50) | ALDH1A1ACHEKDM4EKMT2AMAPT | |
| Benzene SCHEMBL28071205 | 0.91 | ALDH1A1 (0.44) | ALDH1A1ACHEKDM4EKMT2AMAPT | |
| Piperidine SCHEMBL3283269 | 0.90 | ALDH1A1 (0.60) | ALDH1A1KDM4EKMT2AMAPTATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1189061-B1 | Multifunctional erythrocyte reagent containing carbamates and uses | IMMUNOTECH SA (FR) | 2009-12-02 | — | — | EP | claimed |
| CN-1894173-A | Preparation of 18-fluoro-labeled aromatic amino acids | UNIV EBERHARD KARLS (DE) | 2007-01-10 | — | — | CN | claimed |
| US-20020115118-A1 | Multi-functional reagent for erythrocytes | IMMUNOTECH (FR) | 2002-08-22 | — | — | US | claimed |
| US-12590123-B2 | Compounds and methods for treating cancer, viral infections, and allergic conditions | WASHINGTON UNIVERSITY (US) | 2026-03-31 | — | — | US | disclosed |
| EP-3870285-B1 | SYNTHESIS OF ESUBERAPROST PRODRUGS | UNITED THERAPEUTICS CORP (US) | 2025-06-18 | — | — | EP | disclosed |
| US-20250154181-A1 | TREPROSTINIL PRODRUGS | UNITED THERAPEUTICS CORPORATION (US) | 2025-05-15 | — | — | US | disclosed |
| US-12173021-B2 | Treprostinil prodrugs | UNITED THERAPEUTICS CORPORATION (US) | 2024-12-24 | — | — | US | disclosed |
| US-12162853-B2 | Synthesis of esuberaprost prodrugs | UNITED THERAPEUTICS CORPORATION (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240327352-A1 | NOVEL PROCESS FOR THE PREPARATION OF 1-(2-{4-[(4-CARBAMOYLPIPERIDIN-1-YL)METHYL]- N-METHYLBENZAMIDO}ETHYL)PIPERIDIN-4-YL N-({1,1'-BIPHENYL}-2-YL)CARBAMATE | MSN LABORATORIES PRIVATE LTD, R&D CENTER (IN) | 2024-10-03 | — | — | US | disclosed |
| CN-118613156-A | Non-transgenic sunflower plants with increased tolerance to herbicides | 巴斯夫农业种子解决方案美国有限责任公司 | 2024-09-06 | — | — | CN | disclosed |
| US-12049466-B2 | Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors | FORMA THERAPEUTICS, INC. (US) | 2024-07-30 | — | — | US | disclosed |
| CN-1309184-A | Operation of enzymatic vitality of protoporphyrin primary oxidase in eukaryote | NOVARTIS AG (CH) | 2001-08-22 | — | — | CN | disclosed |
| CN-1309638-A | N-substituted naphthamides as neurokinin receptor antagonists | ASTRAZENECA AB (SE) | 2001-08-22 | — | — | CN | disclosed |
| US-20010008892-A1 | Retroviral protease inhibiting compounds | CHEN XIAOQI (US) | 2001-07-19 | — | — | US | disclosed |
| EP-1077977-A1 | RETROVIRAL PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 2001-02-28 | — | — | EP | disclosed |
| WO-1999059994-A1 | RETROVIRAL PROTEASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1999-11-25 | — | — | WO | disclosed |
| EP-0944730-A1 | METHOD FOR PRODUCTION OF D-PROLINE DERIVATIVES | LONZA A.G. (CH) | 1999-09-29 | — | — | EP | disclosed |
| WO-1998027222-A1 | METHOD FOR PRODUCTION OF D-PROLINE DERIVATIVES | LONZA AG (CH) | 1998-06-25 | — | — | WO | disclosed |
| CN-1150820-A | Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotes | CIBA GEIGY AG (CH) | 1997-05-28 | — | — | CN | disclosed |
| EP-0001402-A1 | Substituted piperidinhydroxycarboxylic acid amides, their preparation and their application as light stabilisers | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250154181-A1 | TREPROSTINIL PRODRUGS | TYMP, TK1, DCTPP1 | ALDH1A1 758/4885ACHE 2213/4885KDM4E 3961/4885 |
| US-12590123-B2 | Compounds and methods for treating cancer, viral infections, and allergic conditions | TMPRSS2, TMPRSS4, F2RL3 | ALDH1A1 2827/4885ACHE 4388/4885KDM4E 1739/4885 |
| US-12162853-B2 | Synthesis of esuberaprost prodrugs | DCPS, DNPEP, NPEPPS | ALDH1A1 1494/4885ACHE 1047/4885KDM4E 3376/4885 |
| US-20240327352-A1 | NOVEL PROCESS FOR THE PREPARATION OF 1-(2-{4-[(4-CARBAMOYLPIPERIDIN-1-YL)METHYL]- N-METHYLBENZAMIDO}ETHYL)PIPERIDIN-4-YL N-({1,1'-BIPHENYL}-2-YL)CARBAMATE | CYP4B1, CYP1B1, KDM4B | ALDH1A1 250/4885ACHE 137/4885KDM4E 15/4885 |
| US-12049466-B2 | Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors | USP30, UCHL1, ADRM1 | ALDH1A1 1330/4885ACHE 1432/4885KDM4E 2992/4885 |
| US-12173021-B2 | Treprostinil prodrugs | TYMP, TK1, DCTPP1 | ALDH1A1 758/4885ACHE 2213/4885KDM4E 3961/4885 |
| US-20010008892-A1 | Retroviral protease inhibiting compounds | PREP, DNPEP, SERPINB1 | ALDH1A1 4014/4885ACHE 2682/4885KDM4E 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.